Access brought to you by: LOCKSS
Login
Sorafenib Significantly Improves Event-Free Survival
Reproduced with permission from C Röllig, MD.
Sorafenib Does Not Improve Overall Survival Compared With Placebo
Thank you for your interest in spreading the word on MD Conference Express.
NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.